Coloplast A/S (CPH: COLO.B)
Denmark
· Delayed Price · Currency is DKK 920.20
+0.80 (0.09%)
Aug 30, 2024, 4:59 PM CET
Coloplast Income Statement
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 - 2014 |
| Revenue | 26,303 | 24,500 | 22,579 | 19,426 | 18,544 | 17,939 | Upgrade
|
| Revenue Growth (YoY) | 8.10% | 8.51% | 16.23% | 4.76% | 3.37% | 9.06% | Upgrade
|
| Cost of Revenue | 8,542 | 8,172 | 7,050 | 6,113 | 5,932 | 5,743 | Upgrade
|
| Gross Profit | 17,761 | 16,328 | 15,529 | 13,313 | 12,612 | 12,196 | Upgrade
|
| Selling, General & Admin | 9,676 | 8,633 | 7,802 | 6,247 | 6,079 | 5,963 | Upgrade
|
| Research & Development | 925 | 872 | 866 | 755 | 708 | 692 | Upgrade
|
| Other Operating Expenses | -40 | -25 | -56 | -48 | -29 | -42 | Upgrade
|
| Operating Expenses | 10,560 | 9,479 | 8,610 | 6,956 | 6,765 | 6,620 | Upgrade
|
| Operating Income | 7,201 | 6,849 | 6,919 | 6,357 | 5,847 | 5,576 | Upgrade
|
| Interest Expense | -789 | -638 | -172 | -25 | -30 | -6 | Upgrade
|
| Interest & Investment Income | 154 | 111 | 39 | 11 | 8 | 19 | Upgrade
|
| Currency Exchange Gain (Loss) | -64 | -178 | -134 | 114 | -338 | 2 | Upgrade
|
| Other Non Operating Income (Expenses) | -62 | -78 | -66 | -31 | -32 | -168 | Upgrade
|
| EBT Excluding Unusual Items | 6,440 | 6,066 | 6,586 | 6,426 | 5,455 | 5,423 | Upgrade
|
| Merger & Restructuring Charges | -383 | -118 | -171 | - | - | -43 | Upgrade
|
| Gain (Loss) on Sale of Assets | -3 | -3 | -7 | -4 | - | 16 | Upgrade
|
| Legal Settlements | - | -200 | -300 | -200 | - | -400 | Upgrade
|
| Other Unusual Items | 265 | 280 | 19 | 11 | 11 | 32 | Upgrade
|
| Pretax Income | 6,319 | 6,025 | 6,127 | 6,233 | 5,466 | 5,028 | Upgrade
|
| Income Tax Expense | 1,352 | 1,242 | 1,421 | 1,408 | 1,269 | 1,155 | Upgrade
|
| Net Income | 4,967 | 4,783 | 4,706 | 4,825 | 4,197 | 3,873 | Upgrade
|
| Net Income to Common | 4,967 | 4,783 | 4,706 | 4,825 | 4,197 | 3,873 | Upgrade
|
| Net Income Growth | 3.83% | 1.64% | -2.47% | 14.96% | 8.37% | 0.73% | Upgrade
|
| Shares Outstanding (Basic) | 225 | 215 | 213 | 213 | 213 | 212 | Upgrade
|
| Shares Outstanding (Diluted) | 225 | 216 | 213 | 213 | 213 | 213 | Upgrade
|
| Shares Change (YoY) | 5.87% | 1.27% | -0.19% | -0.05% | 0.09% | 0.33% | Upgrade
|
| EPS (Basic) | 22.11 | 22.21 | 22.15 | 22.67 | 19.74 | 18.24 | Upgrade
|
| EPS (Diluted) | 22.09 | 22.20 | 22.11 | 22.63 | 19.67 | 18.18 | Upgrade
|
| EPS Growth | -1.89% | 0.41% | -2.30% | 15.05% | 8.20% | 0.44% | Upgrade
|
| Free Cash Flow | 1,501 | 3,206 | 4,172 | 4,371 | 3,913 | 3,740 | Upgrade
|
| Free Cash Flow Per Share | 6.68 | 14.88 | 19.61 | 20.50 | 18.35 | 17.55 | Upgrade
|
| Dividend Per Share | 21.000 | 21.000 | 20.000 | 19.000 | 18.000 | 12.000 | Upgrade
|
| Dividend Growth | 5.00% | 5.00% | 5.26% | 5.56% | 50.00% | 9.09% | Upgrade
|
| Gross Margin | 67.52% | 66.64% | 68.78% | 68.53% | 68.01% | 67.99% | Upgrade
|
| Operating Margin | 27.38% | 27.96% | 30.64% | 32.72% | 31.53% | 31.08% | Upgrade
|
| Profit Margin | 18.88% | 19.52% | 20.84% | 24.84% | 22.63% | 21.59% | Upgrade
|
| Free Cash Flow Margin | 5.71% | 13.09% | 18.48% | 22.50% | 21.10% | 20.85% | Upgrade
|
| EBITDA | 8,083 | 7,568 | 7,544 | 6,897 | 6,450 | 6,194 | Upgrade
|
| EBITDA Margin | 30.73% | 30.89% | 33.41% | 35.50% | 34.78% | 34.53% | Upgrade
|
| D&A For EBITDA | 882 | 719 | 625 | 540 | 603 | 618 | Upgrade
|
| EBIT | 7,201 | 6,849 | 6,919 | 6,357 | 5,847 | 5,576 | Upgrade
|
| EBIT Margin | 27.38% | 27.96% | 30.64% | 32.72% | 31.53% | 31.08% | Upgrade
|
| Effective Tax Rate | 21.40% | 20.61% | 23.19% | 22.59% | 23.22% | 22.97% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.